Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.

Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Oncol Rep. 2006 Nov; 16(5):1105-10.

View in: PubMed

subject areas

Antibodies, Neoplasm
Antibody Formation
Autoantibodies
Cyclin-Dependent Kinase Inhibitor p16
DNA, Complementary
Enzyme-Linked Immunosorbent Assay
Humans
Neoplasms
Proto-Oncogene Proteins c-myc
Tumor Suppressor Protein p53

authors with profiles

Jianying Zhang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support